We've found
6,735
archived clinical trials in
Psoriasis
We've found
6,735
archived clinical trials in
Psoriasis
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
NYU Langone Medical Center, Ambulatory Care Center, Department of Dermatology, Clinical Studies Unit

Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Updated: 7/20/2016
A Phase 3, Multi-site, Open-label Study Of The Long Term Safety And Tolerability Of 2 Oral Doses Of Cp-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Status: Enrolling
Updated: 7/20/2016
Click here to add this to my saved trials
